Article
Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.
Epilepsy research - 1 Oct 2018
Citraro Rita, De Sarro Caterina, Leo Antonio, Donato di Paola Eugenio, Palma Ernesto, Russo Emilio, De Sarro Giovambattista
Abstract excerpt
Tolerance to some therapeutic effects of antiepileptic drugs may account for the development of pharmacoresistance in patients with epilepsy. In the present study, following oral acute pretreatment with the new antiepileptic drug perampanel (0.1, 0.3, 1 or 3 mg/kg), we observed that the drug significantly and dose-dependently attenuated the seizure phases (clonus and tonus) of audiogenic seizures in genetically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
